AstraZeneca, Plaintiffs Spar Over Seroquel Expert

Law360, New York (September 11, 2007, 12:00 AM EDT) -- Plaintiffs in the massive multidistrict product liability litigation over the bipolar disorder drug Seroquel have opposed AstraZeneca LP's recommendations for a technical expert, saying the company is pushing for someone who regularly does business with drug companies.

In a motion filed Monday in the U.S. District Court for the Middle District of Florida, the plaintiffs urged the rejection of AstraZeneca's proposed experts and advocated that the court hire Hitachi Consulting.

The wrangling comes in the wake of a judge saying last month that AstraZeneca should be...
To view the full article, register now.